Positive trial data led H.C. Wainwright to raise the price target for Nuvalent, Inc. on June 25, 2025.
2 reports, 1 independent
Updated Jun 25
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Positive trial data led H.C. Wainwright to raise the price target for Nuvalent, Inc. on June 25, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nuvalent, Inc. (United States)
company in Cambridge, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- Unknown outlet
- TipRanksNuvalent price target raised to $140 from $125 at Leerink Leerink raised the firm’s price target on Nuvalent (NUVL) to $140 from $125 and keeps an Outperform rating on the shares. Nuvalent’s zidesamt